PMID- 33807230 OWN - NLM STAT- MEDLINE DCOM- 20210811 LR - 20210811 IS - 2073-4425 (Electronic) IS - 2073-4425 (Linking) VI - 12 IP - 4 DP - 2021 Mar 31 TI - Heterogeneity of the Clinical Presentation of the MEN1 LRG_509 c.781C>T (p.Leu261Phe) Variant Within a Three-Generation Family. LID - 10.3390/genes12040512 [doi] LID - 512 AB - Multiple neuroendocrine neoplasia type 1 (MEN1) is a rare genetic disorder with an autosomal dominant inheritance, predisposing carriers to benign and malignant tumors. The phenotype of MEN1 syndrome varies between patients in terms of tumor localization, age of onset, and clinical aggressiveness, even between affected members within the same family. We describe a heterogenic phenotype of the MEN1 variant c.781C>T (LRG_509t1), which was previously reported only once in a family with isolated hyperparathyroidism. A heterozygous missense variant in exon 4 of the gene was identified in the sequence of the MEN1 gene, i.e., c.781C>T, leading to the amino acid change p.Leu261Phe in a three-generation family. In the screened family, 5/6 affected members had already developed hyperparathyroidism. In the index patient and two other family members, an aggressive course of pancreatic neuroendocrine tumor (insulinoma and non-functioning neuroendocrine tumors) with dissemination was diagnosed. In the index patient, late diagnosis and slow progression of the disseminated neuroendocrine tumor have been observed (24 years of follow-up). The very rare variant of MEN1, LRG_509t1 c.781C>T /p.Leu261Phe (LRG_509p1), diagnosed within a three-generation family has a heterogenic clinical presentation. Further follow-up of the family members should be carried out to confirm the spectrum and exact time of clinical presentation. FAU - Gilis-Januszewska, Aleksandra AU - Gilis-Januszewska A AD - Department of Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland. FAU - Boguslawska, Anna AU - Boguslawska A AUID- ORCID: 0000-0002-1348-3924 AD - Department of Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland. FAU - Hasse-Lazar, Kornelia AU - Hasse-Lazar K AD - Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute-Oncology Centre, Gliwice Branch, 44-102 Gliwice, Poland. FAU - Jurecka-Lubieniecka, Beata AU - Jurecka-Lubieniecka B AD - Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute-Oncology Centre, Gliwice Branch, 44-102 Gliwice, Poland. FAU - Jarzab, Barbara AU - Jarzab B AD - Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute-Oncology Centre, Gliwice Branch, 44-102 Gliwice, Poland. FAU - Sowa-Staszczak, Anna AU - Sowa-Staszczak A AD - Department of Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland. FAU - Opalinska, Marta AU - Opalinska M AD - Department of Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland. FAU - Godlewska, Magdalena AU - Godlewska M AD - Department of Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland. FAU - Grochowska, Anna AU - Grochowska A AD - Department of Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland. FAU - Skalniak, Anna AU - Skalniak A AUID- ORCID: 0000-0001-7871-9347 AD - Department of Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland. FAU - Hubalewska-Dydejczyk, Alicja AU - Hubalewska-Dydejczyk A AD - Department of Endocrinology, Jagiellonian University Medical College, 31-008 Cracow, Poland. LA - eng PT - Journal Article DEP - 20210331 PL - Switzerland TA - Genes (Basel) JT - Genes JID - 101551097 RN - 0 (MEN1 protein, human) RN - 0 (Proto-Oncogene Proteins) SB - IM MH - Adult MH - Amino Acid Substitution MH - Humans MH - Hyperparathyroidism/complications/*genetics MH - Middle Aged MH - Multiple Endocrine Neoplasia Type 1/etiology/*genetics MH - *Mutation, Missense MH - Pedigree MH - Phenotype MH - Poland MH - Proto-Oncogene Proteins/*genetics MH - Young Adult PMC - PMC8067145 OTO - NOTNLM OT - cascade genetic screening OT - hyperparathyroidism OT - multiple endocrine neoplasia type 1 OT - pancreatic neuroendocrine tumor OT - pituitary tumor COIS- The authors declare no conflict of interest. EDAT- 2021/04/04 06:00 MHDA- 2021/08/12 06:00 PMCR- 2021/03/31 CRDT- 2021/04/03 01:26 PHST- 2021/03/05 00:00 [received] PHST- 2021/03/25 00:00 [revised] PHST- 2021/03/29 00:00 [accepted] PHST- 2021/04/03 01:26 [entrez] PHST- 2021/04/04 06:00 [pubmed] PHST- 2021/08/12 06:00 [medline] PHST- 2021/03/31 00:00 [pmc-release] AID - genes12040512 [pii] AID - genes-12-00512 [pii] AID - 10.3390/genes12040512 [doi] PST - epublish SO - Genes (Basel). 2021 Mar 31;12(4):512. doi: 10.3390/genes12040512.